We believe the world is changing faster than ever

Join a Two Sigma Ventures portfolio company to help shape the future of technology.
Leverage our network to build your career.
Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Sr. Director, Head of Translational Medicine - Oncology



San Francisco, CA, USA
Posted on Saturday, May 13, 2023

The Opportunity

The heart of insitro’s strategy is the combination of novel, cutting edge methods in machine learning, human biology at scale and molecular discovery that address key bottlenecks in the drug development pipeline. We are searching for an outstanding physician scientist with expertise in the utilization of human imaging, soluble biomarker, germline and somatic genetic data sets to help guide our oncology drug discovery strategy. In this role you will be responsible for aligning and advancing our internal and partnered programs with a relentless focus on unequivocally improved patient clinical outcomes. You will work with cross-functional teams and serve as a bridge between ML enabled laboratory models, internal and collaborative drug discovery teams, and human data at scale to inform our oncology drug discovery and development strategy. You will inform the strategy for using clinical data at scale combined with advanced ML to inform our understanding of disease progression, treatment resistance, and for identifying clinically relevant patient subpopulations. You will be an integral part of the rapidly expanding Oncology Therapeutic Area and work closely with the executive team to develop an advanced machine learning-enabled drug discovery strategy.

Your primary duties will be to:

  • Play a key strategic role in integration of the patient perspective to inform disease modeling and drug discovery efforts, including understanding the standard of care, areas of unmet need, and identifying viable target-patient profiles.
  • Partner with colleagues in data science & machine learning (DSML) and in corporate development to identify critical data assets and/or commission the generation of data for discovery efforts in oncology.
  • Collaborate closely with data science & machine learning (DSML) colleagues to define machine learning (ML) models for clinical data to inform our understanding of patient trajectory and patient subpopulations and to identify novel endpoints for clinical trials.
  • Assist drug discovery teams to prepare IND-enabling data packages in alignment with clinical development objectives.
  • Longer-term, partner with market planning and commercial development colleagues on market research and target-patient profiles for new programs.
  • Contribute as a clinical area expert dedicated to translational approaches and early clinical development.
  • Participate in efforts to model and design ML-enabled clinical trials for internal and/or partnered programs.
  • Participate in strategic overview of presentations, publications, and internal/ external communications along with accountable project and program leadership.

You will be joining as the founding team of a biotech startup that has long-term stability due to significant funding, but yet is very much in formation. A lot can change in this early and exciting phase, providing many opportunities for significant impact. You will work closely with a very versatile team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and outcomes. Join us, and help make a difference to patients!

About You

  • MD or MD/PhD in a technical field (oncology, immuno-oncology, cell & molecular biology, etc.) or equivalent, with 8+ years of postdoctoral experience.
  • Experience working with cancer patients, patient data, patient trajectories/disease progression and clinical trial design.
  • Experience with biomarker data sets such as; clinical imaging, proteomics, metabolomics, and transcriptomics.
  • Familiarity with pioneering oncology translational models (patient-derived organoids, patient derived xenografts, primary metastatic etc)
  • Experience working as part of a high-performance team, including goal setting and contributing to a culture of effective, high-quality methods development and reducing those methods to a practical implementation.
  • Excellent teamwork, communication, time management and organization skills
  • Strong verbal and written communication skills across all levels both within an organization and with external partners.
Compensation & Benefits at insitro
Our target starting salary for successful US-based applicants for this role is $250,000 - $290,000. To determine starting pay, we consider multiple job-related factors including a candidate’s skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
  • 401(k) plan with employer matching for contributions
  • Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees), as well as mental health and well-being support
  • Open, flexible vacation policy
  • Paid parental leave
  • Quarterly budget for books and online courses for self-development
  • Support to occasionally attend professional conferences that are meaningful to your career growth and development
  • New hire stipend for home office setup
  • Monthly cell phone & internet stipend
  • Access to free onsite baristas and cafe with daily lunch and breakfast
  • Access to free onsite fitness center
  • Commuter benefits
About insitro
insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience, oncology and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.